COVID -19 associated candidemia: from a shift in fungal epidemiology to a rise in azole drug resistance
Description
Our understanding of fungal epidemiology and the burden of antifungal drug resistance in COVID-19-associated candidemia (CAC) patients is limited. Therefore, we conducted a retrospective multicenter study in Iran to explore clinical and
